NCT04556188 The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa
| NCT ID | NCT04556188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Helse Nord-Trøndelag HF |
| Condition | Rheumatic Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2016-03-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2016-03-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this bi-directional program of education, training and research activities based on sustainable development goals aim is to develop cardiac surgery service in Ethiopia. The aim is to evaluate the short and long-term outcome of cardiac surgery for rheumatic heart disease in a low-income country compared to individuals not offered cardiac surgery due to limited availability of the service. Second aim is to evaluate the quality of anticoagulant therapy in patients after cardiac surgery for rheumatic heart disease in a low-income country .
Eligibility Criteria
Inclusion Criteria: * Cardiac surgery due to rheumatic heart disease at the governmental Black Lion University Hospital during the bi-directional programme of education, training and Research to establish Cardiac surgery service Exclusion Criteria: * Not willing or able to provide written informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04556188 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, studying Rheumatic Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04556188 currently recruiting?
Yes, NCT04556188 is actively recruiting participants. Contact the research team at havard.dalen@ntnu.no for enrollment information.
Where is the NCT04556188 trial being conducted?
This trial is being conducted at Addis Ababa, Ethiopia, Bergen, Norway, Oslo, Norway, Trondheim, Norway.
Who is sponsoring the NCT04556188 clinical trial?
NCT04556188 is sponsored by Helse Nord-Trøndelag HF. The trial plans to enroll 200 participants.